Companies will work to discover inhibitors for target.

Argenta Discovery added a second two-year drug discovery project to its deal with Genentech. Scientists from the two companies will exploit Argenta’s expertise in computer-aided drug design, medicinal chemistry, and biology to discover new chemical entities acting against a second undisclosed drug target defined by Genentech.

The agreement provides options to further expand the relationship, including opportunities to pursue additional discovery projects.

Previous articleBiotech Has Larger Role in Providing Clean Energy
Next articlePathogenic Content of Infection-Causing Bacteria Sequenced